Markets
← Back to Stocks
EW
EDWARDS LIFESCIENCES CORP
Health Care · Health Care Equipment
$82.55
-0.37%
Vol: 0.1M
Araverus Market Read
Thursday, March 19, 2026
Edwards Lifesciences declines 1.26% in after-hours despite 22% annual gain driven by medical device momentum and analyst optimism
Edwards Lifesciences experienced a 1.26% decline in after-hours trading to $84.02 from a prior close of $85.09, yet the stock has achieved 22.1% appreciation over the past year driven by growth in its medical device segments. The company trades within a 52-week range of $65.94 to $87.89, with 21 analysts maintaining Buy recommendations and an average price target of $96.46 suggesting 13% upside from current levels. The near-term selloff appears to be profit-taking amid strong fundamental momentum and favorable analyst sentiment.
Price 50d 200d
Previous Market Reads
2 of 2 days↓
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$47.9B
P/E (TTM)45.6
Forward P/E24.9
Beta0.93
Div Yield—
Prev Close$82.86
RSI (14-Day)
39Neutral
0305070100
52-Week Range
$65.94$82.55$87.89
From High-6.1%
From Low+25.2%
Moving Averages
50d SMA
$82.48+0.1%
200d SMA
$80.40+2.7%
Price above both MAs — bullish structure.
Returns
1W
-2.4%
1M
+4.5%
3M
-3.3%
6M
+9.8%
1Y
+17.4%
YTD
-3.3%
Volume
Today62K
20d Avg4.7M
Ratio0.01x